Market News
Smart Trading. Simplified.
Power Your Portfolio With Advanced Forecasting
Go after the same opportunities as the ultra-rich by using market forecasting so you can find the best trades. This breakthrough technology helps you build a more secure financial future because it removes all guesswork.
For a limited time, see a LIVE demonstration of the technology specifically made to help independent traders jump on trends at the most opportune time.
3 Best Social Media Stocks To Buy
The question isn’t whether to buy social media stocks. The debate about whether social media will stick has been over for years. In the current environment, business leaders know that social media marketing is a must to stay competitive, and many are transitioning key functions like customer service and technical support to their social media […]
The End of Alzheimer's?
Jeff Bezos is quietly pouring his riches into a secretive project that could mean the end of Alzheimer's. Goldman Sachs & a Big Pharma giant have invested billions into this small biotech.
Early investors who get in by June 2, 2021, could turn every $1,000 into $1.1 million.
6 Stocks That Could Be Worth Millions
Some companies offer plenty of growth potential as they attack new markets with better products or open up new categories entirely. They’re pretty rare, and certainly not easy to find. But the following 6 stocks might just promise you millions – if you’re patient enough, and willing to play the long game… [#6] DermTech, Inc. […]
A Rare Opportunity to Turn $1,000 into $461,800
On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. The Joint Chiefs of Staff calls this new weapon "Unstoppable." This under-the-radar company is not yet a household name.
Our research proves that anyone who gets in now could turn $1,000 into $461,800 >>>
5 Investing Mistakes to Avoid In Your 20s
Investing Mistake #1 – Ignoring Investing Altogether Do you have a 401(k) at work? Are you a participant? Get off to a good beginning by signing up for an employer-matched 401(k)* at work. Otherwise, you are turning down, if not throwing away, free money. *A 401(k) represents an employer-sponsored account, designed for retirement. It permits […]
Stock Market Whiz Kid Works 1 Hour a Day. Makes Millions.
He was living with his parents. Two years later he had $5 million to play with - all because of this 1 EXTRA INCOME strategy.
To see how he did it click here.
How Does A Pairs Trade Work?
One of the best ways to create more portfolio balance during volatile times is to engage in pairs trading. Pairs trading represents a plan for hedging the risk of trading stocks by opening opposing positions in 2 related stocks. This strategy allows you to potentially profit, regardless of market conditions. While pairs trading was traditionally […]
The World's First $20 Trillion Drug?
One small biotech holds the key to a revolution in treating Alzheimer's. Jeff Bezos, Goldman Sachs & a Big Pharma giant have invested billions into this unknown biotech.
Our research shows that anyone who gets in by June 2, 2021 could turn every $1,000 into $1.1 million.
Early investors who get in by June 2, 2021, could turn every $1,000 into $1.1 million.
Bumble Stock vs Match: Which Is Best?
Bumble Inc (NASDAQ:BMBL) is the most recent dating site to go public. It gained a lot of buzz in 2021 from investors after its IPO, but it dipped below the IPO price after its first reported quarter. This has some investors considering Match Group Inc (NASDAQ:MTCH) as an alternative. But which is the better investment […]
Jeff Bezos, Goldman Sachs and a Big Pharma giant have invested billions into this stock.
On August 23, 2018, this small biotech won a patent for a treatment that could help as many as 50 million people...and save the U.S. as much as $20 TRILLION. Jim Cramer says a drug like this would be "The Biggest Drug Ever." And our research shows that anyone who gets in today could turn every $1,000 into $1.1 million.
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment